1 active not recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Active not recruiting 1 |
Follow ceritinib: new trials by email Literature Review of ceritinib trials Research Report on ceritinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study ceritinib - ALK Positive Malignancies | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 233 | 2015-12-11 | 2026-09-17 |
Neoplasms (1)
Australia (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · China (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Japan (1) · Lebanon (1) · Malaysia (1) · Poland (1)